Clinical Trial Update: Clinical Evaluation of Anti-CHIKV Hyperimmune Intravenous Immunoglobulins [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical evaluation of anti-Chikungunya virus hyperimmune intravenous immunoglobulin for Chikungunya infection; the trial status is listed as UNKNOWN …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chikungunya

Drugs mentioned

• Anti-CHIKV Hyperimmune Intravenous Immunoglobulins (Chikungunya virus-specific hyperimmune intravenous immunoglobulin)

Snippet

Sponsor: Centre Hospitalier Universitaire de la Guadeloupe | Conditions: Chikungunya Virus Infection | Phase 1, Phase 2 | Status: UNKNOWN